Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04692064 · ClinicalTrials.gov registry record
mCVI Confirmatory Clinical Study: Algorithm Verification
A clinical trial of Algorithm Verification, sponsored by Intelomed.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT04692064 is a study of Algorithm Verification that has completed, run by Intelomed. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04692064, a study of Algorithm Verification, has completed, sponsored by Intelomed.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This single center confirmatory clinical study is to verify the algorithm of mCVI® to accurately capture pulse rate and respiratory rate in 20 healthy subjects in comparison to commercially-available Masimo pulse oximeter devices. This is a non significant risk device.
Conditions Studied
Interventions
- OTHER There is no intervention
Study Locations (1)
Pennsylvania
- InteloMed, Inc. - Cranberry Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-02-03 |
| Est. Completion | 2021-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04692064
The ClinicalTrials.gov registry entry for NCT04692064 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intelomed, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Algorithm Verification appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention is the first listed.
NCT04692064 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04692064 about?
NCT04692064 is a clinical study titled "mCVI Confirmatory Clinical Study: Algorithm Verification". This single center confirmatory clinical study is to verify the algorithm of mCVI® to accurately capture pulse rate and respiratory rate in 20 healthy subjects in comparison to commercially-available Masimo pulse oximeter devices. This is a non significant risk device.
What is the current status of trial NCT04692064?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-02-03. Estimated completion is 2021-02-21.
What conditions does trial NCT04692064 study?
This clinical trial studies the following conditions: Algorithm Verification.
What interventions are being tested in trial NCT04692064?
The interventions under investigation include: There is no intervention (OTHER).
Who is sponsoring clinical trial NCT04692064?
This trial is sponsored by Intelomed, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04692064 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.